International Forum regarding practices related to donor haemoglobin and iron

Vox Sanguinis

Volumn 111, Issue 4, 2016, Pages 449-455

  Goldman, M ^a   Magnussen, K ^b   Gorlin, J ^c   Lozano, M ^d   Speedy, J ^e   Keller, A ^f   Pink, J ^e   Leung, J N S ^g   Chu, C C Y ^g   Lee, C K ^g   Faed, J ^h   Chay, J ⁱ   Tan, H H ⁱ   Teo, D ^j   Djoudi, R ^k   Woimant, G ^l   Fillet, A M ^m   Castren J ⁿ   Miflin, G ^o   Vandewalle, G C ^p   Compernolle, V ^p   Cardenas, J M ^q   Infanti, L ^r   Holbro, A ^s,t   Buser, A ^s,t   van den Hurk, K ^u   Yahalom, V J ^v   Gendelman, V ^v   Shinar, E ^v   Eder, A F ^w   Steele, W R ^w   O'Neill, E M ^w   Kamel, H ^x   Vassallo, R ^x   Delage, G ^y   Lebrun, A ^y   Robillard, P ^y   Germain, M ^y   Gandhi, M ^z   West, K A ^aa   Klein, H G ^aa   more..

^a CANADIAN BLOOD SERVICES   (Canada)

^b Mental Health Center Glostrup   (Denmark)

^c Memorial Blood Centers   (United States)

^d HOSPITAL CLÍNIC   (Spain)

^e AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^f Australian Red Cross   (Australia)

^g Hong Kong Red Cross Blood Transfusion Service   (Hong Kong)

^h UNIVERSITY OF OTAGO   (New Zealand)

ⁱ HEALTH SCIENCES AUTHORITY   (Singapore)

^j Centre for Transfusion Medicine   (Singapore)

^k ETABLISSEMENT FRANÇAIS DU SANG   (France)

^l EFS   (France)

^m Medical Department   (France)

ⁿ FINNISH RED CROSS BLOOD SERVICE   (Finland)

^o NHS BLOOD AND TRANSPLANT   (United Kingdom)

^p Rode Kruis Vlaanderen   (Belgium)

^q Centro Vasco de Transfusion y Tejidos Humanos   (Spain)

^r University Blood Donation Service Basel   (Switzerland)

^s Blood Transfusion Centre   (Switzerland)

^t UNIVERSITY HOSPITAL BASEL   (Switzerland)

^u SANQUIN RESEARCH   (Netherlands)

^v MAGEN DAVID ADOM   (Israel)

^w AMERICAN RED CROSS   (United States)

^x Blood Systems Incorporated   (United States)

^y HÉMA QUÉBEC   (Canada)

^z MAYO CLINIC   (United States)

^aa NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON;

APHERESIS; ARTICLE; AUSTRALIA; BLOOD BANK; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; ERYTHROPOIESIS; EUROPE; FERRITIN BLOOD LEVEL; FINLAND; FOOD AND DRUG ADMINISTRATION; GENERAL PRACTITIONER; HEALTH CARE POLICY; HEALTH SERVICE; HEMOGLOBIN BLOOD LEVEL; HONG KONG; HUMAN; IRON DEFICIENCY; IRON STORAGE; IRON THERAPY; ISRAEL; NETHERLANDS; NEW ZEALAND; NORTH AMERICA; PRIORITY JOURNAL; RED CROSS; RISK FACTOR; SINGAPORE;

EID: 84983598072     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12431     Document Type: Article

References (33)

1. Popovsky MA: Anemia, iron depletion, and the blood donor: it's time to work on the donor's behalf. Transfusion 2012; 52:688–692
2. Gorlin J: Iron man pentathlon or “we have met the enemy and they is us!”. Transfusion 2014; 54:747–749
3. Rigas AS, Sorensen CJ, Petersen MS, et al.: Predictors of iron levels in 14,737 Danish blood donors: results from the Danish blood donor study. Transfusion 2014; 54:789–796
4. Goldman M, Uzicanin S, Scalia V, et al.: Iron deficiency in Canadian blood donors. Transfusion 2014; 54:775–779
5. AABB Association Bulletin 2012 #12-03: Strategies to monitor, limit, or prevent iron deficiency in blood donors. Available from: www.aabb.org/programs/publication/bulletins/Pages/ab-12-03.aspx [Last accessed 2 August 2016]
6. Delaney M, Schellhas KG, Young S, et al.: Blood center practice and education for blood donors with anemia. Transfusion 2011; 51:929–936
7. O'Meara A, Infanti L, Stebler C, et al.: The Value of routine ferritin measurement in blood donors. Transfusion 2011; 51:2183–2188
8. Magnussen K, Ladelund S: Handling low hemoglobin and iron deficiency in a blood donor population: 2 years’ experience. Transfusion 2015; 55:2473–2478
9. Magnussen K, Ladelund S: Handling low hemoglobin and iron deficiency in a blood donor population. ISBT Sci Ser 2016; 1:235–242
10. Mast AE, Bialkowski W, Bryant B, et al.: A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. Transfusion 2016; 55:1588–1597
11. Kiss JE, Brambilla D, Glynn SA, et al.: Oral iron supplementation after blood donation. A randomized clinical trial (HEIRS). JAMA 2015; 313:575–583
12. Marks DC, Speedy J, Robinson KL, et al.: An 8-week course of 45 mg of carbonyl iron daily reduces iron deficiency in female whole blood donors aged 18 to 45 years: results of prospective randomized controlled trial. Transfusion 2014; 54:780–788
13. Salvin H, Pasricha SR, Marks DC, et al.: Iron deficiency in blood donors: a national cross-sectional study. Transfusion 2014; 54:2434–2444
14. Marks DC, Speedy J, Robinson K, et al.: Post-donation iron supplementation with 45 mg carbonyl iron is effective and well tolerated. Transfusion 2011; 51:98A
15. Faed JM: Insights from a donor intervention trial to manage low iron status in new female donors. Transfusion 2015; 55:S3, 96A, SP111
16. HemoCue Hb 201+® Operating Manual [package insert]. Ängelholm, Sweden, HemoCue AB, 2002
17. ® [package insert]. Sarl, France, Floxia International Inc., 2015
18. Ortiz R, Toblli JE, Romero JD, et al.: Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study. J Matern Fetal Neonatal Med 2011; 24:1347–1352
19. Toblli JE, Brignoli R: Iron(III)-hydroxide polymaltose complex in iron deficiency anemia/review and meta-analysis. Arzneimittelforschung 2007; 57:431–438
20. Smith GA, Fisher SA, Dorée C, et al.: A systematic review of factors associated with the deferral of donors failing to meet low haemoglobin thresholds. Transfus Med 2013; 23:309–320
21. O'Meara A, Infanti L, Stebler C, et al.: The value of routine ferritin measurement in blood donors. Transfusion 2011; 51:2183–2188
22. Stern M, O'Meara A, Infanti L, et al.: Prognostic value of red blood cell parameters and ferritin in predicting deferral due to low hemoglobin in whole blood donors. Ann Hematol 2012; 91:775–780
23. Food and Drug Administration, Department of Health and Human Services: Requirements for blood and blood components Intended for Transfusion or for further manufacturing use; Final Rule. Federal Reg 2015; May 22. Available at http://www.regulations.gov/document?D=FDA-2006-N-0040-0009. Last accessed August 9, 2016.
24. Steele WR, Flynn DP, Eder AF: Iron supplement use and iron deficiency knowledge and awareness among active donors before and after the implementation of new donor education materials. Vox Sang 2014; 107(Suppl 1):9 (abstract)
25. Mast AE, Bialkowski W, Bryant B, et al.: Iron status of donors in STRIDE, a randomized, blinded, placebo-controlled study of education and iron supplementation for mitigation of iron deficiency in frequent blood donors. Transfusion 2015; 55(Suppl 3):20A (abstract)
26. Standards for Blood Banks and Transfusion Services, 29th edn. Bethesda, MD, AABB Press, 2014:60. Reference Standard 5.4.1A
27. Custer B, Bravo M, Bruhn R, et al.: Predictors of hemoglobin recovery or deferral in blood donors with an initial successful donation. Transfusion 2014; 54:2267–2275
28. Bravo M, Custer B, Vassallo R, et al.: Identifying blood donors with absent iron stores: assessing the value of hemoglobin, age and history of red cell donation. Transfusion 2015; 55(Suppl):88A–89A
29. Duffy KJ, Benike M, Stubbs JR, et al.: Lower incidence of hemoglobin deferral when whole blood interval is expanded to 12 weeks. Transfusion 2014; 54:122A
30. Duffy KJ, Bryant SC, Benike M, et al.: Incidence of low iron stores in blood donors with acceptable hemoglobin levels: a single center experience. Transfusion 2013; 53:111A–112A
31. Gandhi MJ, Duffy K, Benike M, et al.: Effect of increasing hemoglobin cutoff in male donors and increasing interdonation interval in whole blood donors at a hospital-based blood donor center. Transfusion 2012; 52:1880–1888
32. Bryant BJ, Yau YY, Arceo SM, et al.: Iron replacement therapy in the routine management of blood donors. Transfusion 2012; 52:1566–1575
33. Bryant BJ, Hopkins JA, Arceo SM, et al.: Evaluation of low red blood cell mean corpuscular volume in an apheresis donor population. Transfusion 2009; 49:1971–1976